Parker Institute for Cancer Immunotherapy

Other

Parker Institute for Cancer Immunotherapy is based in San Francisco, United States.

Parker Institute accelerates development of breakthrough cancer immunotherapies through collaborative research network.

Early Stage
Biotech
Healthcare
Headquarters
San Francisco, United States
Founded
2016
Portfolio Companies
6
Total Investments
8
Last Investment
Jul 2025
Geographic Focus
United States
Use investor data through the API.
Example request
curl "https://indexed.vc/api/v1/investors/parker-institute-for-cancer-immunotherapy?depth=slim" -H "X-API-Key: YOUR_API_KEY"

Indexed holds 6 portfolio companies and 8 funding rounds for this investor. The full record is or through the API.

Investment Thesis

Break barriers in cancer immunotherapy research to rapidly develop curative immune therapies.

Parker Institute for Cancer Immunotherapy was founded in 2016. Parker Institute for Cancer Immunotherapy has made 8 investments. Parker Institute for Cancer Immunotherapy's portfolio includes Georgiamune, Tmunity and ArsenalBio. Focus areas include Biotech and Healthcare.

Portfolio6

Co-investors24

Sign up to view co-investors

24 co-investors across 31 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×16 · Corporate VC ×2 · Other ×2 · 24 shared rounds

Investment History

Data from Indexed.vcUpdated

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Parker Institute for Cancer Immunotherapy on Indexed.vc
<a href="https://indexed.vc/investors/parker-institute-for-cancer-immunotherapy"><img src="https://indexed.vc/api/badge/investor/parker-institute-for-cancer-immunotherapy" alt="Parker Institute for Cancer Immunotherapy on Indexed.vc" width="260" height="76" /></a>